Advertisement

Picture Berlin Partner BIO 2024 International Convention San Diego 650x100px
Organisation › Details

Fertin Pharma (Group)

Fertin Pharma is a privately held company with more than 850 employees and operations in Denmark, Canada, and India. It is a leading contract development and manufacturing organization (CDMO), specializing in the research, development and production of gums, pouches, liquefiable tablets, and other solid oral systems for the delivery of active ingredients, including nicotine, where it is a leading producer of Nicotine Replacement Therapy (NRT) solutions. The company and its employees bring significant scientific experience and know-how to the development of innovative solutions, driving above-category growth across new and existing business areas. In 2020, Fertin Pharma generated net revenues of DKK 1.1 billion (approximately USD 160 million). The transaction value represents a multiple of around 15 times Fertin Pharma’s 2020 EBITDA *

 

Period Start 2021-07-01 existent
Product Industry oral drug delivery technology
Person Person Halling, Peter (Fertin Pharma 202107 CEO)
     
Region Region Denmark_oo
  Country Denmark
  City n. a. 
    Address record changed: 2021-07-14
     
Basic data Employees E: 501 to 1,000 (2021-07-01)
  Currency DKK
  Annual sales 1,100,000,000 (revenues, net, consolidated (2020) 2020-12-31)
     
    * Document for »About Section«: Philip Morris International Inc.. (7/1/21). "Press Release: Philip Morris International Announces Agreement to Acquire Fertin Pharma". Lausanne.
     
   
Record changed: 2024-02-12

Advertisement

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Philip Morris (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture EBD Group World of Partnering Opportunities 650x300px




» top